Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex

Figure 1

Analysis of CSF biomarkers. (a) Total tau, (b) phosphorylated tau, (c) beta-amyloid peptide (1–42), (d) the ratio of p-tau to A𝛽42. AD: Alzheimer’s disease, ALS: amyotrophic lateral sclerosis, C: disease control, Kii: Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex, and PD: Parkinson’s disease.

(a)

(b)

(c)

(d)